Kenneth T. Kim, M.D. – FDA Inspection, Nov 22, 2024

Record Details

This FDA Inspection record concerns Kenneth T. Kim, M.D., with an inspection on November 22, 2024, issued by the Los Angeles District Office, covering biologics.

Company: Kenneth T. Kim, M.D.
Inspection Date: November 22, 2024
Product Type: Biologics
Office: Los Angeles District Office
Person: Korina Serrano

View Company Profile

ID · c0372017-a94b-4ce7-a885-d250ad285b6d

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1255953
FDA center: Biologics
Project area: Vaccine, Allergenic, and Live Biotherapeutic Products
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kenneth T. Kim, M.D.

FDA Inspection

Kenneth T. Kim, M.D.November 22, 2024